FDA Investigator Kenneth R Merritt

Kenneth R Merritt has conducted inspections on 235 sites in 11 countries as of 08 Nov 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
235
Last Inspection Date:
08 Nov 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Canada, Bulgaria, Chile, Japan, Argentina, Czechia, Norway, Poland, Belgium, Peru
FDA Investigators that have inspected at least one site in common with Kenneth R Merritt:
Abby Lmozeke Baker, Althea A Williams, Amanda B Athey, Andrea A Branche, Ann B Borromeo, Anna E Fain, Anthony D Peterson, Barbara D Wright, Barbara I Rogolsky, Barbara T Carmichael, Bichsa T Tran, Bonnie E Conley, Bonnie E Pierson, Brandon C Heitmeier, Brentley S Collins, Brian A Graves, Brian S Lynch, C Tyfrans Francis, Caitlin L Almonrode, Carl A Huffman, III, Carol F Robinson, Carolyn E Barney, Casey L Hamblin, Charles M Edwards, Cherie T Parker, Cheryl G Scott, Cheryl L Watson, Christie B Rice, Christopher J Adams, Claire M Minden, Clendening, Clifton C Francis, Clinton J Lott, Cody D Rickman, Colleen C Kerr, Cynthia L Medlin, Dana M Klimavicz, Danielle M Maddox, David R Heiar, Deborah A Greco, Demario L Walls, Diana M Rand, Dolores Harper, Donna D Gallien, MPH, Dr. Koffi A Amegadje, Dr. Roy A Blay, PhD, Dr. Sriram Subramaniam, PhD, Eddie J Rigsby, Edward H Maticka, Elizabeth D Battles, Elizabeth D Connell, Emily E Smith, Erica M Katherine, Erika M Wilkerson, Fabian Nchaparro Rodriguez, Francis A Guidry, Gail L Katz, George J Flynn, Geraldine D Sanders, Gloria J Horner, Gretchen M Laws, Holly M Scott, Hristu B Chepa, Hultman, Jason D Abel, Jason K Ferry, Javelle P Spann, Jean A Peeples, Jeremy W Rotton, John A Iwen, John E Russell, Jr, Johnathan M Crayton, Juanelma H Palmer, Julius I Jones, June P Page, Justin N Henson, Karen Gale Sego, Karen R Smallwood, Kari L Batey, Katherine A Indingaro, Kimberly A Dutzek, Kimberly Cdelk Brooks, Kimberly D Tucker, Kimberly J Hoffmeister, Kimberly L Mcmillan, Kip J Hanks, Konsuela Y Glass, Krista W Whitten, Lacey J Chessor, Laressa R Gray, Laura E Garcia, Laura L Staples, Lawrence A Butler, LCDR Randall L Morris, Lillie D Witcher, Linda A Gregory Duty, Llopis, Lori S Lawless, Lura D Baquero, Lura D Kelly, M A Abel I, Mahaffey, Marcus F Yambot, Marcus L Head, Maressa L Mills, Margaret E Slimbach, Marie A Fadden, Marie F Morin, Markeesa M Scales, Marvin D Jones, Mary A Millner, Mary T Carden, Mathew T Thomas, MD, Melanie L Drayton, Meocha V Whaley, Michael R Duran, Michael T Nehring, Myla T Collins, Nancy M Espinal, Natasha N Mccants, Nicholas L Hunt, Patricia S Smith, Patrick C Dooley, Paul Mouris, Randy L Clarida, Reba A Gates, Richard J Bashay, Robert E Hultman, Samantha J Bradley, Samantha J Pinizzotto, D V M, Sandy L Atkins, Saundrea A Munroe, Shelton L Stribling, Shirhonda D Thorn, Shirley J Berryman, Shondra N Gipson, Shrikant N Pagay, Stanley M Shepperson, Stephanie A Cochran, Stephanie Mangigian, MS/OSH, RN, Stephen G Mclane, Steven D Dittert, Susan O Oladeji, Tamira D Wesley, Tammara D Perry, Thomas B Smith, Thomas O Morgan, Thomas R Stanley, Tiana M Mckinley, Timothy H Vo, Tonia L Sawyer, Tony E Bable, Torrance J Slayton, Traci M Armand, Travis E Chapman, Vaishali J Patel, Veronica Fuentes, MS, Walter L Fava, Wendy R Blame, Whitney M White, Wilvor K Butler, Xikui Chen (nmi), PhD, Yumi J Hiramine

Kenneth R Merritt's Documents

Publish Date Document Type Title
May, 2010 EIR Ian W Flinn M D, Ph D - EIR, 2010-05-21
May, 2000 FDA 483 Response Clintrials Bioresearch, Ltd. - Form 483R, 2000-06-02
December, 2000 EIR American Red Cross Blood Services Tennessee Valley Region - EIR, 2000-12-28
February, 2005 EIR Dr. Marco A. Camere - EIR, 2005-02-11
May, 2009 FDA 483 Central Admixture Pharmacy Services Inc - Form 483, 2009-05-15
November, 2002 EIR SpinalGraft Technologies LLC - EIR, 2002-11-13
January, 2001 EIR Biomat USA, Inc - EIR, 2001-01-26
December, 2003 FDA 483 Allied Analytical Laboratory Services - Form 483, 2003-12-19
September, 2001 EIR DCI Donor Services Tissue Bank - EIR, 2001-09-12
November, 2002 EIR Community Blood Center dba Community Tissue Services - EIR, 2002-11-16
November, 2001 FDA 483 West TN Regional Blood Center, dba Lifeline Blood Services - Form 483, 2001-11-09
June, 2001 FDA 483 Kaplan, Robert J., M.D. - Form 483, 2001-06-28
September, 2001 FDA 483 Response DCI Donor Services Tissue Bank - Form 483R, 2001-11-28
May, 2001 FDA 483 Response Andrzej Z. Sawicki, M.D., Ph.D. - Form 483R, 2001-05-25
July, 2005 FDA 483 Advancing Sight Network North Alabama Regional Office - Form 483, 2005-07-13
February, 2005 FDA 483 Dr. Marco A. Camere - Form 483, 2005-02-11
November, 2002 EIR United Donor Services - EIR, 2002-11-14
March, 2007 EIR Valerie K Arnold MD - EIR, 2007-03-11
September, 2001 FDA 483 DCI Donor Services Tissue Bank - Form 483, 2001-09-12
June, 2002 FDA 483 ZLB Bioplasma Inc - Form 483, 2002-06-05
November, 2001 FDA 483 Response West TN Regional Blood Center, dba Lifeline Blood Services - Form 483R, 2001-11-12
June, 2001 EIR Kaplan, Robert J., M.D. - EIR, 2001-06-28
May, 2001 EIR Andrzej Z. Sawicki, M.D., Ph.D. - EIR, 2004-07-21
September, 2002 EIR AT Laboratory - EIR, 2002-09-19
November, 2002 FDA 483 Community Blood Center dba Community Tissue Services - Form 483, 2002-11-16
May, 2000 FDA 483 Clintrials Bioresearch, Ltd. - Form 483, 2000-05-08
September, 2004 EIR Marietta Corp. dba Voyant Beauty - EIR, 2005-10-17
March, 2006 EIR Cetero Research - EIR, 2006-03-01
May, 2000 EIR Clintrials Bioresearch, Ltd. - EIR, 2000-07-12
December, 2002 EIR Biomat USA, Inc - EIR, 2002-12-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more